ARCH Venture Partners IX, LLC - Net Worth and Insider Trading

ARCH Venture Partners IX, LLC Net Worth

The estimated net worth of ARCH Venture Partners IX, LLC is at least $106 Million dollars as of 2024-09-27. ARCH Venture Partners IX, LLC is the 2201 Interest of corporation controlled by you of Brii Biosciences Ltd and owns about 90,410,418 shares of Brii Biosciences Ltd (HKSE:02137) stock worth over $106 Million. Details can be seen in ARCH Venture Partners IX, LLC's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that ARCH Venture Partners IX, LLC has not made any transactions after 2021-07-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of ARCH Venture Partners IX, LLC

ARCH Venture Partners IX, LLC Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, ARCH Venture Partners IX, LLC owns 1 companies in total, including Brii Biosciences Ltd (HKSE:02137) .

Click here to see the complete history of ARCH Venture Partners IX, LLC’s form 4 insider trades.

Insider Ownership Summary of ARCH Venture Partners IX, LLC

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02137	Brii Biosciences Ltd	2021-07-13	2201 Interest of corporation controlled by you

ARCH Venture Partners IX, LLC Latest Holdings Summary

ARCH Venture Partners IX, LLC currently owns a total of 1 stock. ARCH Venture Partners IX, LLC owns 90,410,418 shares of Brii Biosciences Ltd (HKSE:02137) as of July 13, 2021, with a value of $106 Million.

Latest Holdings of ARCH Venture Partners IX, LLC

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02137	Brii Biosciences Ltd	2021-07-13	90,410,418	1.17	105,780,189

Holding Weightings of ARCH Venture Partners IX, LLC

ARCH Venture Partners IX, LLC Form 4 Trading Tracker

According to the SEC Form 4 filings, ARCH Venture Partners IX, LLC has made a total of 1 transactions in Brii Biosciences Ltd (HKSE:02137) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Brii Biosciences Ltd is the sale of 90,410,418 shares on July 13, 2021, which brought ARCH Venture Partners IX, LLC around $0.

Insider Trading History of ARCH Venture Partners IX, LLC

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

ARCH Venture Partners IX, LLC Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

ARCH Venture Partners IX, LLC Ownership Network

Ownership Network List of ARCH Venture Partners IX, LLC

No Data

Ownership Network Relation of ARCH Venture Partners IX, LLC

ARCH Venture Partners IX, LLC Owned Company Details

What does Brii Biosciences Ltd do?

Who are the key executives at Brii Biosciences Ltd?

ARCH Venture Partners IX, LLC is the 2201 Interest of corporation controlled by you of Brii Biosciences Ltd. Other key executives at Brii Biosciences Ltd include 2101 Beneficial owner Hong Zhi , 2201 Interest of corporation controlled by you Xyxy Holdings Ltd. , and 2201 Interest of corporation controlled by you Tong Xiaomeng .

Brii Biosciences Ltd (HKSE:02137) Insider Trades Summary

Over the past 18 months, ARCH Venture Partners IX, LLC made no insider transaction in Brii Biosciences Ltd (HKSE:02137). Other recent insider transactions involving Brii Biosciences Ltd (HKSE:02137) include a net sale of 0 shares made by Hong Zhi ,

In summary, during the past 3 months, insiders sold 0 shares of Brii Biosciences Ltd (HKSE:02137) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brii Biosciences Ltd (HKSE:02137) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Brii Biosciences Ltd (HKSE:02137)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brii Biosciences Ltd Insider Transactions

No Available Data

ARCH Venture Partners IX, LLC Mailing Address

Above is the net worth, insider trading, and ownership report for ARCH Venture Partners IX, LLC. Currently GuruFocus does not have mailing address information for ARCH Venture Partners IX, LLC.

Discussions on ARCH Venture Partners IX, LLC

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.